🔴 Moderna is trading 3.26% down in pre-market after recent rally pullback

MRNA is trading at $50.18, down 3.26% in pre-market, as the stock experiences profit-taking following a dramatic two-day surge.

• The initial rally saw the stock surge 15.84% on January 21 after announcing five-year melanoma vaccine data.
• The positive data showed a 49% reduction in cancer recurrence.
• Broader market weakness (S&P 500 -0.19%) may also be contributing to the modest decline.